abmart-banner
Global R&D Pipeline
My Favorite
Hot Targets:
ACP3
Back
Total number of drugs
14
Phase II and later clinical stages
7.1%
Involving companies
11
Main therapeutic areas
Neoplasms
Data Table
Data Chart
Select Row
Fixed Column
Download Table
Molecule Info
R&D and Market Info
ADC Info
DrugDrug Name EnDrug TypeTreatment FieldMechanism of ActionOriginatorDeveloperIndicationHighest Development StageHighest Development Stage (China)Approved Countries/RegionsApproved TimeApproved Time (China)Special ReviewADC TypeADC LinkerADC PayloadADC DARDrug NameAntibody TypeADC Linking SiteOperation
DNA-based Vaccine Targeting Prostatic Acid Phosphatase(University of Wisconsin Madison)DNA-based Vaccine Targeting Prostatic Acid Phosphatase(University of Wisconsin Madison)Shared antigen vaccine DNA vaccineNeoplasms Digestive System Disorders Endocrinology and Metabolic Disease Urogenital Diseasesacid phosphatase 3 stimulants ImmunostimulantsUniversity of Wisconsin-MadisonMadison Vaccines, Inc.University of Wisconsin-MadisonPhase 2DNA-based Vaccine Targeting Prostatic Acid Phosphatase(University of Wisconsin Madison)
detail  >
HB-300HB-300Recombinant vector vaccine Therapeutic vaccineNeoplasms Urogenital Diseasesacid phosphatase 3 modulators Prostate-specific antigen modulators ImmunostimulantsHOOKIPA Pharma, Inc.HOOKIPA Pharma, Inc.Phase 1/2HB-300
detail  >
[68]Ga-OncoACP3[68]Ga-OncoACP3Small molecule drug Diagnostic radiopharmaceuticalsNeoplasms Urogenital Diseasesacid phosphatase 3 inhibitorsPhilochem AGPhilogen SpAPhilochem AGPhase 168 Ga[68]Ga-OncoACP3
detail  >
[177]Lu-OncoACP3[177]Lu-OncoACP3Small molecule drug Therapeutic radiopharmaceuticalsNeoplasms Urogenital Diseasesacid phosphatase 3 modulatorsPhilochem AGPhilochem AGPreclinical177 Lu[177]Lu-OncoACP3
detail  >
[18]F-OncoACP3[18]F-OncoACP3Small molecule drug Diagnostic radiopharmaceuticalsNeoplasms Urogenital Diseasesacid phosphatase 3 modulatorsPhilochem AGPhilochem AGPreclinical18 F[18]F-OncoACP3
detail  >
[225]Ac-OncoACP3[225]Ac-OncoACP3Small molecule drug Therapeutic radiopharmaceuticalsNeoplasms Urogenital Diseasesacid phosphatase 3 modulatorsPhilochem AGPhilochem AGPreclinical225 Ac[225]Ac-OncoACP3
detail  >
Anti ACP-3 antibody(Philochem)Anti ACP-3 antibody(Philochem)Monoclonal antibodyNeoplasms Urogenital Diseasesacid phosphatase 3 inhibitorsUniversitätsSpital ZürichPhilochem AGPhilochem AGUniversitätsSpital ZürichPreclinicalAnti ACP-3 antibody(Philochem)
detail  >
ICT-801ICT-801CAR-TNeoplasms Urogenital Diseasesacid phosphatase 3 inhibitorsInnovative Cellular Therapeutics Co., Ltd.Innovative Cellular Therapeutics Co., Ltd.PreclinicalICT-801
detail  >
RYZ-701RYZ-701Therapeutic radiopharmaceuticalsNeoplasms Urogenital Diseasesacid phosphatase 3 modulatorsRayzebio, Inc.Rayzebio, Inc.PreclinicalRYZ-701
detail  >
RYZ-711RYZ-711Diagnostic radiopharmaceuticalsNeoplasms Urogenital Diseasesacid phosphatase 3 modulatorsRayzebio, Inc.Rayzebio, Inc.PreclinicalRYZ-711
detail  >
Total 14 data
1
2